Thursday, March 26, 2015 6:35:50 AM
"Easton Pharmaceuticals is placing serious consideration to moving forward with filing a form 10 or an S1 with the Securities and Exchange Commission to become a reporting issuer and to graduate up to the OTCBB or the OTCQB exchange. The difference with being an SEC reporting company is that its financial statements would be audited by a US GAAP auditor and filed on the SEC's Edgar system. Currently, its financial statements are validated by an attorney and filed on the OTC Markets exchange (OTC: EAPH) which is considered close to the same level of transparency with financial statements filed with the SEC, being a reporting SEC filer would require 8K's and other filings to be submitted on a more timely basis for material transactions."
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM